HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanisms that may be involved in calcium tolerance of the diabetic heart.

Abstract
In diabetes the hearts exhibit impaired membrane functions, but also increased tolerance to Ca2+ (iCaT) However, neither the true meaning nor the molecular mechanisms of these changes are fully understood. The present study is devoted to elucidation of molecular alterations, particularly those induced by non-enzymatic glycation of proteins, that may be responsible for iCaT of the rat hearts in the stage of fully developed, but still compensated diabetic cardiomyopathy (DH). Insulin-dependent diabetes (DIA) was induced by a single i.v. dose of streptozotocin (45 mg.kg-1). Beginning with the subsequent day, animals obtained 6 U insulin daily. Glucose, triglycerides, cholesterol and glycohemoglobin were investigated in blood. ATPase activities, the kinetics of activation of (Na,K)-ATPase by Na+ and K+, further the fluorescence anisotropy of diphenyl-hexatriene as well as the order parameters of membranes in isolated heart sarcolemma (SL) were also investigated. In addition, the degree of glycation and glycation-related potency for radical generation in SL proteins were determined by investigating their fructosamine content. In order to study calcium tolerance of DH in a 'transparent' model, hearts were subjected to calcium paradox (Ca-Pa, 3 min of Ca2+ depletion; 10 min of Ca2+ repletion). In this model of Ca(2+)-overload, Ca2+ ions enter the cardiac cells in a way that is not mediated by receptors. Results revealed that more than 83% of the isolated perfused DH recovered, while the non-DIA control hearts all failed after Ca-Pa. DH exhibited well preserved SL ATPase activities and kinetics of (Na,K)-ATPase activation by Na+, even after the Ca-Pa. This was considered as a reason for their iCaT. Pretreatment and administration of resorcylidene aminoguanidine (RAG 4 or 8 mg.kg-1) during the disease prevented partially the pathobiochemical effects of DIA-induced glycation of SL proteins. DIA-induced perturbations in anisotropy and order parameters of SL were completely prevented by administration of RAG (4 mg.kg-1). Although, the latter treatment exerted little influence on the (Na,K)-ATPase activity, it decreased the calcium tolerance of the DH. Results are supporting our hypothesis that the glycation-induced enhancement in free radical formation and protein crosslinking in SL may participate in adaptive mechanisms that may be also considered as 'positive' and are responsible for iCaT of the DH.
AuthorsA Ziegelhöffer, T Ravingerová, J Styk, J Seboková, I Waczulíková, A Breier, A Dzurba, K Volkovová, J Cársky, L Turecký
JournalMolecular and cellular biochemistry (Mol Cell Biochem) Vol. 176 Issue 1-2 Pg. 191-8 (Nov 1997) ISSN: 0300-8177 [Print] Netherlands
PMID9406161 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Glucose
  • Guanidines
  • Hemoglobins
  • Triglycerides
  • Fructosamine
  • Cholesterol
  • Sodium
  • Ca(2+) Mg(2+)-ATPase
  • Calcium-Transporting ATPases
  • Sodium-Potassium-Exchanging ATPase
  • Potassium
  • Calcium
Topics
  • Animals
  • Blood Glucose
  • Body Weight
  • Ca(2+) Mg(2+)-ATPase (metabolism)
  • Calcium (metabolism)
  • Calcium-Transporting ATPases (metabolism)
  • Cardiomyopathies (complications, metabolism)
  • Cholesterol (blood)
  • Diabetes Mellitus, Experimental (blood, complications, enzymology)
  • Fructosamine (analysis)
  • Guanidines (pharmacology)
  • Hemoglobins (metabolism)
  • Male
  • Potassium (pharmacology)
  • Rats
  • Rats, Wistar
  • Sarcolemma (drug effects, enzymology, metabolism)
  • Sodium (pharmacology)
  • Sodium-Potassium-Exchanging ATPase (metabolism)
  • Triglycerides (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: